Multiple Sclerosis
Multiple sclerosis is a qualifying condition in Georgia’s Medical Cannabis Patient Registry. A diagnosis allows you to discuss eligibility, but certification depends on the physician’s review and medical judgment. Research on cannabis and MS is strongest for some patient-reported spasticity outcomes; it does not establish a cure or a treatment that repairs nerve damage.
$100 · Private 15-minute phone consultation with a Georgia-licensed physician. GMMC serves adults age 18 and older throughout Georgia.
Book through Calendly. Our team sends an eVisit link for the telemedicine visit, and payment is collected through eVisit after the visit. If our physician determines that you do not qualify, any consultation fee paid will be refunded.
Does Multiple Sclerosis Qualify in Georgia?
Yes. The Georgia Department of Public Health lists multiple sclerosis among its qualifying conditions. Its current list does not attach a severe or end-stage restriction to MS. GMMC’s service is for adults only.
The physician reviews your diagnosis, medical history, records, and suitability for certification. A qualifying diagnosis does not guarantee approval or establish that a particular cannabis product is an appropriate treatment option.
Georgia’s patient guidance now describes a possession limit of up to 12,000 milligrams of THC. Older descriptions of a 20-fluid-ounce limit should not be used as the current program summary. Use official state guidance for current requirements.
If you already have a card, check its expiration and the applicable physician certification requirements. An eligibility consultation, a state card, and the decision to use a cannabis product are separate steps.
Understanding Multiple Sclerosis and MS Symptoms
Multiple sclerosis (MS) is a chronic disorder affecting the central nervous system, including the brain and spinal cord. The immune system attacks myelin, the protective covering of nerve fibers. The resulting disruption can affect movement, sensation, vision, and other functions.
MS symptoms can include muscle weakness, numbness, tingling, fatigue, balance problems, vision changes, bladder problems, and pain. Symptoms affect people differently. A symptom list cannot diagnose MS; diagnosis and treatment belong with the treating clinician.
Some people have relapses followed by periods of recovery, while progressive MS can involve worsening over time. The National Institute of Neurological Disorders and Stroke explains the disease, diagnostic evaluation, and treatment approaches.
When preparing for the consultation, describe your own experience rather than assuming that every listed symptom applies. Explain which multiple sclerosis symptoms interfere most with daily activities and which concerns are new.
Muscle Spasticity, Muscle Spasms, and Neuropathic Pain
Muscle spasticity involves increased muscle tone and can cause stiffness or painful spasms. Neuropathic pain arises from nerve injury or dysfunction and can feel burning, shooting, or electric. These are different concerns even when they occur together.
Explain the location and timing of your symptoms. For example, describe whether muscle stiffness makes dressing difficult, whether muscle spasms interrupt rest, or whether neuropathic pain limits a particular activity.
Do not assume that every painful symptom is central neuropathic pain or that worsening symptoms are simply part of MS. Your neurologist or treating clinician can assess the cause and decide whether additional evaluation is needed.
The medical cannabis consultation can review eligibility and questions about safety. It does not replace a neurological examination, urgent assessment, or management of an MS relapse.
Treatment Options Before Adding Medical Cannabis
MS care includes disease-modifying therapies, management of relapses, symptom treatment, and rehabilitation. Medicines and other therapies have different purposes. Slowing disease activity is different from reducing discomfort.
A neurologist may select injectable, oral, or infusion treatment depending on the person’s disease course and health history. Treatment decisions about those medicines should remain with the clinician managing MS.
Symptomatic treatment may address muscle spasticity, neuropathic pain, bladder symptoms, or other concerns. Physical therapy and occupational therapy may be part of care. A physical therapist can help assess mobility and function.
Medical cannabis should not be presented as a replacement for disease-modifying treatment. Do not stop or adjust your existing treatment regimen because of this page or because another person reports that cannabis helped.
Bring the full medication list to the consultation. Include prescriptions, nonprescription medicines, supplements, CBD oil, and cannabis products already used. Tell the physician about benefits, adverse effects, and treatments you could not tolerate. Also disclose if you are pregnant or breastfeeding, because medical marijuana is not recommended during pregnancy or breastfeeding.
What Research Says About Cannabis and MS
Cannabis-based medicine has been studied for symptomatic treatment in people with MS. Research includes oral formulations, an oral cannabis extract, synthetic cannabinoids, and nabiximols, an oromucosal spray containing THC and CBD.
A 2022 Cochrane systematic review included 25 randomized controlled trials involving 3,763 participants. Most studies were short, and the evidence search extended through December 2021.
The review found moderate-certainty evidence that nabiximols improves short-term patient-reported spasticity compared with placebo. Evidence for chronic neuropathic pain was much less certain. Health-related quality-of-life effects were also uncertain, and adverse effects could lead some people to discontinue treatment.
These findings do not establish that every cannabis product produces the same result. A standardized preparation evaluated in a placebo-controlled trial is not interchangeable with an unspecified CBD oil or whole-plant cannabis product.
A 2025 meta-analysis evaluated nine clinical trials involving 2,544 patients and reported improvements in spasticity measures. Different preparations and outcome measures still limit how directly results can be applied to an individual product.
Muscle Spasticity: A Specific Research Question
Spasticity is the clearest area of research discussed here. It is reasonable to ask a physician whether findings from studies of MS-related spasticity are relevant to your situation, especially if standard approaches have been difficult to tolerate.
Ask which preparation was studied and what the study measured. A patient’s rating of muscle stiffness, an examination finding, and the ability to complete daily tasks are related but different outcomes.
Research on resistant spasticity does not mean that cannabis is appropriate for everyone with muscle spasms. The physician needs to consider your medicines, balance, cognition, prior reactions, and treatment goals.
Neuropathic Pain: Keep Expectations Realistic
Some people seek medicinal cannabis for pain relief. However, the cited review does not provide a reliable basis for promising substantial neuropathic pain reduction in MS.
Ask the clinician how your pain has been assessed and what other treatments remain appropriate. A burning sensation, muscle cramp, or aching joint may require different evaluation and management.
An individual report of pain relief matters to that person, but it does not establish a predictable benefit for another patient. GMMC does not guarantee relief or reduced use of other medicines.
Symptom Management Is Different From Disease Modification
Symptom relief does not establish that cannabinoids change relapse rates or slow progression in people with multiple sclerosis. Do not interpret a report of less stiffness as proof of repaired myelin, fewer lesions, or slower progression.
Laboratory research on cannabinoids and the immune system is not enough to establish those outcomes in people with multiple sclerosis. More research does not create a reason to abandon proven neurological care.
Keep appointments with your neurologist and continue recommended monitoring. Any proposed add-on therapy should be discussed in the context of your current treatment.
How to Discuss Clinical Trials With Your Doctor
When you read about medicinal cannabis, look for the exact question a study tested. Was the aim to treat spasticity, assess neuropathic pain, or evaluate another symptom? Ask whether participants resembled your circumstances and whether the preparation is relevant to the product being discussed.
Randomized controlled trials can compare a treatment with placebo, while observational studies describe experiences without the same control over treatment assignment. Neither a personal testimonial nor the phrase “medical cannabis” identifies the strength of the evidence.
A systematic review or meta-analysis brings studies together, but it cannot remove every difference among them. Oral formulations and an oromucosal spray may differ from other cannabis products. Short follow-up also limits what can be concluded about ongoing cannabis use.
Ask the physician to distinguish moderate-certainty evidence from low-certainty evidence and to explain what remains uncertain. For people with MS, the practical question is whether an approach is appropriate within the existing care plan, with its possible benefits and adverse effects considered together.
Keep the conversation focused on your MS symptoms. Medicinal cannabis is not a substitute for checking a new neurological problem, reviewing other treatments, or deciding with your neurologist how best to treat MS.
Medical Marijuana, THC, CBD Oil, and Study Products
Medical marijuana and medicinal cannabis are terms used for varied products. Their composition, strength, and regulation can differ. The name alone does not identify what was studied or whether it is suitable for a particular person.
THC can produce psychoactive effects and impairment. CBD does not produce the same intoxication, but CBD oil should not be assumed to be risk free or proven effective for MS.
Cannabinoids interact with the endocannabinoid system and cannabinoid receptors. A possible biological mechanism is a reason to investigate a treatment, not proof of clinical benefit.
The FDA’s cannabis resource distinguishes specific approved prescription medicines from other cannabis products. Those approvals should not be represented as approval of dispensary cannabis to treat MS.
This page does not recommend a strain, THC:CBD ratio, route, or dosage. Do not copy a clinical trial dose or another patient’s routine. Ask the physician or pharmacist about a proposed product and its potential interactions.
Adverse Effects and Safety Questions
Cannabis can affect attention, memory, movement, and mood. The NIH cannabis health resource describes dizziness, drowsiness, dry mouth, anxiety, and other unwanted effects.
For people with MS who already have balance problems or fatigue, discuss how additional impairment could affect daily life. Tell the clinician about previous falls, cognitive concerns, mental health history, and past reactions to cannabis. Discuss whether cannabis could worsen existing attention or memory concerns.
Medical use does not remove the risk of impairment. Do not drive or operate machinery while impaired. Discuss transportation and work responsibilities before starting or changing a product.
Tell the physician about all medicines and supplements, including cannabis based medications. A clinician or pharmacist should assess potential interactions; this page does not establish a universally safe combination with MS drugs, sleep medicines, or pain medicines.
Ask what to do if unwanted effects occur. Do not assume that a new symptom is caused by MS rather than a product or another medical issue. Keep your treating team informed about cannabis use. Disclose heart disease and your personal or family psychiatric history so the clinician can assess your circumstances.
Health-Related Quality of Life and Practical Goals
People with MS often want a discussion focused on daily functioning rather than a broad promise of feeling better. Prepare one or two specific priorities for the visit.
Examples include understanding why a muscle spasm disrupts a task, discussing persistent neuropathic pain, or asking whether a proposed product could worsen fatigue. These are questions for review, not guaranteed benefits of cannabis.
A symptom journal can help organize the discussion. Note when symptoms occur, what you were doing, what medicines you used, and whether there were unwanted effects. You do not need to create an elaborate record to book.
Avoid judging a treatment only by whether it makes you sleepy or less aware of a symptom. Ask how the treating clinician would assess a worthwhile benefit and whether the tradeoffs are acceptable.
GMMC’s eligibility consultation does not promise ongoing MS management or dosing supervision. If you need additional care arrangements, ask the team what the service includes before booking.
Preparing for Your Adult GMMC Consultation
Have available diagnosis information and a current medication list ready. The physician determines which records are needed. Useful information may include neurologist notes, relevant imaging reports, and prior treatment history.
Write down the most difficult MS symptoms and how they affect daily life. Describe both what you hope to understand and what concerns you about medical cannabis.
Tell the physician about prior cannabis use, even if the experience was unpleasant or did not help. Include CBD oil and other cannabis products in the medication discussion.
Choose a private place for the phone consultation and check that you have received the eVisit link from our team. Contact GMMC if you have an administrative question about joining the visit.
If medical records are requested, ask for the appropriate secure submission process. Do not put records, patient identifiers, or sensitive clinical details into public website chat.
Questions to Bring to the Physician
Is my documented MS diagnosis sufficient for the eligibility review?
What additional records are needed?
Which research findings are relevant to my symptoms?
Could a proposed product interact with my existing treatment regimen?
What adverse effects matter most given my balance, fatigue, or cognitive concerns?
Which questions should I discuss with my neurologist?
What happens after certification if it is appropriate?
The consultation should help clarify the next step. It should not depend on a promise that cannabis will work or that approval is automatic.
Booking, Payment, and Refunds
GMMC offers a $100 private 15-minute phone consultation with a Georgia-licensed physician. Adults age 18 and older can book from throughout Georgia.
Choose your appointment on Calendly.
Our team sends the eVisit link for your telemedicine visit.
Attend the consultation and discuss your diagnosis, history, and eligibility.
Payment is collected through eVisit after the visit.
If our physician determines that you do not qualify, any consultation fee paid will be refunded.
This is a consultation service. There is no merchandise to return or replace. The consultation fee is separate from state registry charges and any cannabis purchases.
Booking does not guarantee certification, symptom improvement, or a particular product recommendation. The physician makes the eligibility decision after reviewing your circumstances.
For general scheduling assistance, use the contact page. Use the appropriate private process for medical information.
Georgia Registry Steps After Certification
If certification is appropriate, the physician submits information to the state registry. DPH reviews the submission and provides instructions for the separate state card payment.
DPH lists a $30 card fee plus a $3.75 online service fee, five-year card validity, and up to 10 business days from processed payment to receipt. Follow the actual instructions you receive rather than treating the consultation receipt as completion of the registry process.
The Georgia medical cannabis program describes annual physician certification. Card expiration and physician certification requirements should both be checked. Georgia law exempts patients with incurable or irreversible conditions from annual certification. Confirm whether this applies to your documented condition and registry record with your certifying physician or Georgia DPH. Review the certification exception and card renewal.
For current product rules and authorized sellers, consult the Georgia Access to Medical Cannabis Commission. Do not assume that a product studied elsewhere is available or authorized in Georgia.
If you already have a card, see our renewal information. Ask about your circumstances before booking as a new patient.
Frequently Asked Questions
Can People With Multiple Sclerosis Get a Georgia Card?
Multiple sclerosis is listed as a qualifying condition. A physician still reviews the diagnosis, history, and appropriateness of certification. GMMC serves adults only.
Does MS Have to Be Severe or End-Stage?
The current DPH qualifying-condition list says multiple sclerosis without that restriction. The physician’s medical judgment still determines certification.
Does Medical Marijuana Cure MS?
No. The research discussed here concerns symptoms. It does not establish a cure, repaired nerve damage, or a replacement for disease-modifying therapy.
Can Cannabis Help Muscle Spasticity?
Studies of particular cannabinoid preparations support some short-term patient-reported spasticity improvements. This does not guarantee that a particular dispensary product will help you.
Is Cannabis Proven to Relieve MS Neuropathic Pain?
The cited Cochrane review describes uncertainty for chronic neuropathic pain. Discuss your pain and treatment options with the clinician rather than expecting a guaranteed result.
Should I Stop My Current MS Treatment?
Do not stop or adjust prescribed treatment based on this page. Talk with your neurologist before changing medicines or adding a cannabis product.
Is CBD Oil Enough to Treat MS Symptoms?
This page does not recommend CBD oil as an MS treatment. Different products and study preparations cannot be assumed to have the same effects.
Can I Book Outside Atlanta?
Yes. GMMC’s adult service is available throughout Georgia. Book through Calendly and receive the eVisit link from our team.
Do I Pay Through Shopify or Calendly?
Payment is collected through eVisit after the telemedicine visit. Calendly is used for booking. The state card fee and cannabis purchases are separate.
What if the Physician Says I Do Not Qualify?
Any consultation fee paid will be refunded if our physician determines that you do not qualify for medical cannabis certification.
Does the Card Guarantee a Product Is Safe for Me?
No. Access, effectiveness, interactions, and individual safety are different questions. Discuss a proposed product with the physician or pharmacist.
What if My Symptoms Suddenly Change?
Contact your treating clinician for assessment. An eligibility appointment is not a substitute for urgent care or evaluation of a possible relapse.
Book an Adult Eligibility Consultation
If you have a documented MS diagnosis and want to discuss Georgia medical cannabis eligibility, book a $100 private 15-minute phone consultation with a Georgia-licensed physician.
Our team sends the eVisit link after you book on Calendly. Payment is collected through eVisit after the visit. If the physician determines that you do not qualify, any consultation fee paid will be refunded.
Continue your neurological care while exploring eligibility. The appointment can clarify the next step without promising a cure or guaranteed symptom relief.